ADDvise has received an order from AstraZeneca in Wuxi, China, to
deliver laboratory furnishings and safety ventilation to a chemistry
laboratory. The order amounts to 1.3 MSEK and will be delivered during
2016. The order will be delivered to AstraZeneca\'s research and
development laboratory in Wuxi.
\- This is the second order from AstraZeneca in Wuxi in a short time. It
is exciting that we have continued confidence from AstraZeneca and that
ADDvise products continue to be competitive in the Chinese market, says
Rikard Akhtarzand CEO of ADDvise, in a comment on today\'s order.
For further information, please contact:
Rikard Akhtarzand, CEO, +46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
www.addvisegroup.com
About ADDvise Group AB
ADDvise Group AB (publ) is an expansive group which through its
subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise
Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical
Tables Inc offers comprehensive solutions in the form of products and
services to healthcare and research facilities. ADDvise Group\'s
customers are located in both the private and public sectors. The
Company\'s share is listed on First North Premier and Mangold
Fondkommission AB, +46 8-503015 50, is the company\'s Certified Adviser
and liquidity provider.
